Perfromance Wealth Partners’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Perfromance Wealth Partners's PFE Position: Q1 2026 in Review
Perfromance Wealth Partners reduced its Pfizer (PFE) stake by 1.8% in Q1 2026, selling an estimated $4.66K and leaving 9,337 shares worth $262K. The position accounts for 0.01% of the portfolio, ranked #175.
Perfromance Wealth Partners first reported a position in PFE in Q4 2021 and has held it in 17 quarters since. The position peaked at $708K in Q4 2021. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Perfromance Wealth Partners held 9,337 shares of Pfizer worth $262K as of Q1 2026.
- Perfromance Wealth Partners sold 175 Pfizer shares in Q1 2026, an estimated $4.66K.
- Pfizer made up 0.01% of Perfromance Wealth Partners's portfolio in Q1 2026, its #175 holding.
- Perfromance Wealth Partners first reported a position in Pfizer in Q4 2021 and has held it in 17 quarters since.
- Perfromance Wealth Partners's Pfizer position peaked at $708K in Q4 2021.
- 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Perfromance Wealth Partners's 13F filing for Q1 2026, filed 10 Apr 2026.